Pairing 3D-Printing with Nanotechnology to Manage Metabolic Syndrome

References

• O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12. doi:10.1111/obr.12229
   PubMed Web of Science ®Google Scholar
• Do Vale Moreira NC, Hussain A, Bhowmik B, et al. Prevalence of metabolic syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1217–1224. doi:10.1016/j.dsx.2020.05.043
   PubMed Web of Science ®Google Scholar
• Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):1–9. doi:10.1186/s12889-017-4041-1
   PubMed Web of Science ®Google Scholar
• Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metab Syndr Relat Disord. 2013;11(2):71–80. doi:10.1089/met.2012.0122
   PubMed Web of Science ®Google Scholar
• Li X, Cao C, Tang X, et al. Prevalence of metabolic syndrome and its determinants in newly-diagnosed adult-onset diabetes in china: a multi-center, cross-sectional survey. Front Endocrinol (Lausanne). 2019;10:1–9. doi:10.3389/fendo.2019.00661
   PubMed Web of Science ®Google Scholar
• Yadav D, Mahajan S, Subramanian SK, Bisen PS, Chung CH, Prasad GB. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India. Glob J Health Sci. 2013;5(6):142–155. doi:10.5539/gjhs.v5n6p142
   PubMedGoogle Scholar
• Al-Rubeaan K, Bawazeer N, Al Farsi Y, et al. Prevalence of metabolic syndrome in Saudi Arabia - a cross sectional study. BMC Endocr Disord. 2018;18(1):1–9. doi:10.1186/s12902-018-0244-4
   PubMed Web of Science ®Google Scholar
• Naghipour M, Joukar F, Nikbakht HA, et al. High prevalence of metabolic syndrome and its related demographic factors in north of Iran: results from the PERSIAN guilan cohort study. Int J Endocrinol. 2021;2021:1–9. doi:10.1155/2021/8862456
   Web of Science ®Google Scholar
• US Department of Health and Human Services. National diabetes statistics report, 2020. Natl Diabetes Stat Rep; 2020:1–30.
   Google Scholar
• DeBoer MD, Filipp SL, Gurka MJ. Use of a metabolic syndrome severity z score to track risk during treatment of prediabetes: an analysis of the diabetes prevention program. Diabetes Care. 2018;41(11):2421–2430. doi:10.2337/dc18-1079
   PubMed Web of Science ®Google Scholar
• Belete R, Ataro Z, Abdu A, Sheleme M. Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):1–13. doi:10.1186/s13098-021-00641-8
   PubMed Web of Science ®Google Scholar
• Arefian M, Mirzaei M, Eshtiagh-Hosseini H, Frontera A. A survey of the different roles of polyoxometalates in their interaction with amino acids, peptides and proteins. Dalt Trans. 2017;46(21):6812–6829. doi:10.1039/C7DT00894E
   PubMed Web of Science ®Google Scholar
• Alizadeh H, Mirzaei M, Saljooghi AS, et al. Coordination complexes of zinc and manganese based on pyridine-2,5-dicarboxylic acid N -oxide: DFT studies and antiproliferative activities consideration. RSC Adv. 2021;11(59):37403–37412. doi:10.1039/D1RA08258B
   PubMed Web of Science ®Google Scholar
• Moradi HS, Momenzadeh E, Asar M, et al. Bioactivity studies of two copper complexes based on pyridinedicarboxylic acid N-oxide and 2,2′-bipyridine. J Mol Struct. 2022;1249:131584. doi:10.1016/J.MOLSTRUC.2021.131584
   Web of Science ®Google Scholar
• Sabouri Z, Sabouri M, Amiri MS, Khatami M, Darroudi M. Plant-based synthesis of cerium oxide nanoparticles using Rheum turkestanicum extract and evaluation of their cytotoxicity and photocatalytic properties. Mater Technol. 2020;1–14. doi:10.1080/10667857.2020.1863573
   Web of Science ®Google Scholar
• Charbgoo F, Bin AM, Darroudi M. Cerium oxide nanoparticles: green synthesis and biological applications. Int J Nanomedicine. 2017;12:1401–1413. doi:10.2147/IJN.S124855
   PubMed Web of Science ®Google Scholar
• Ashraf J, Mughal EU, Alsantali RI, et al. 2-Benzylidenebenzofuran-3(2 H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies. RSC Adv. 2021;11(56):35077–35092. doi:10.1039/D1RA07379F
   PubMed Web of Science ®Google Scholar
• Hashemzadeh A, Drummen GPC, Avan A, et al. When metal–organic framework mediated smart drug delivery meets gastrointestinal cancers. J Mater Chem B. 2021;9(19):3967–3982. doi:10.1039/D1TB00155H
   PubMed Web of Science ®Google Scholar
• Pivari F, Mingione A, Brasacchio C, Soldati L. Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients. 2019;11(8):1837. doi:10.3390/nu11081837
   PubMed Web of Science ®Google Scholar
• Kim M, Kim Y. Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutr Res Pract. 2010;4(3):191. doi:10.4162/nrp.2010.4.3.191
   PubMed Web of Science ®Google Scholar
• Rivera-Mancía S, Trujillo J, Chaverri JP. Utility of curcumin for the treatment of diabetes mellitus: evidence from preclinical and clinical studies. J Nutr Intermed Metab. 2018;14:29–41. doi:10.1016/j.jnim.2018.05.001
   Google Scholar
• Sahebkar A, Saboni N, Pirro M, Banach M. Curcumin: an effective adjunct in patients with statin-associated muscle symptoms? J Cachexia Sarcopenia Muscle. 2017;8(1):19–24. doi:10.1002/jcsm.12140
   PubMed Web of Science ®Google Scholar
• Marton LT, Pescinini-e-Salzedas LM, Camargo MEC, et al. The effects of curcumin on diabetes mellitus: a systematic review. Front Endocrinol. 2021;12. doi:10.3389/fendo.2021.669448
   PubMed Web of Science ®Google Scholar
• Vogenberg FR, Barash CI, Pursel M. Personalized medicine - Part 1: evolution and development into theranostics. P T. 2010;35(10):560–567.
   PubMedGoogle Scholar
• Lesko LJ. Personalized medicine: elusive dream or imminent reality? Clin Pharmacol Ther. 2007;81(6):807–816. doi:10.1038/sj.clpt.6100204
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Felimban RI, Tayeb HH, et al. Development of multi-compartment 3d-printed tablets loaded with self-nanoemulsified formulations of various drugs: a new strategy for personalized medicine. Pharmaceutics. 2021;13(10):1733. doi:10.3390/pharmaceutics13101733
   PubMed Web of Science ®Google Scholar
• USP 41-NF 36. The United States pharmacopeia national formulary. Twinbrook Parkway, Rockville, MD: The United States Pharmacopeial Convention; 2018.
   Google Scholar
• Ahmed OAA, Ahmed TA, Abdel-naim AB, Khedr A, Banjar ZM, Afouna MI. Enhancement of in vitro skin transport and in vivo hypoglycemic efficacy of glimepiride transdermal patches. Trop J Pharm Res. 2014;13(8):1207–1213. doi:10.4314/tjpr.v13i8.3
   Web of Science ®Google Scholar
• Ahmed TA, Elimam H, Alrifai AO, et al. Rosuvastatin lyophilized tablets loaded with flexible chitosomes for improved drug bioavailability, anti-hyperlipidemic and anti-oxidant activity. Int J Pharm. 2020;588:119791. doi:10.1016/j.ijpharm.2020.119791
   PubMed Web of Science ®Google Scholar
• Mahajan TC, Deshmukh SB, Badgujar VL, Chhajed PN, Patil JA. RP-HPLC method development and validation for estimation of metformin, voglibose, glimepiride in bulk and combined tablet dosage forms. Int J Chem Pharm Sci. 2016;4(12):697–702.
   Google Scholar
• El-Say KM, Ahmed TA, Aljefri AH, El-Sawy HS, Fassihi R, Abou-Gharbia M. Oleic acid–reinforced PEGylated polymethacrylate transdermal film with enhanced antidyslipidemic activity and bioavailability of atorvastatin: a mechanistic ex-vivo/in-vivo analysis. Int J Pharm. 2021;608:121057. doi:10.1016/j.ijpharm.2021.121057
   PubMed Web of Science ®Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–2474. doi:10.1111/J.1572-0241.1999.01377.X
   PubMed Web of Science ®Google Scholar
• Godfrey KR, Arundel PA, Dong Z, Bryant R. Modelling the Double Peak Phenomenon in Pharmacokinetics. IFAC; Vol. 42, 2009. doi:10.3182/20090812-3-DK-2006.0001
   Google Scholar
• Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63(3):288–294. doi:10.1016/j.ejpb.2005.12.005
   PubMed Web of Science ®Google Scholar
• Chang RK, Shojaei AH. Effect of a lipoidic excipient on the absorption profile of compound UK 81252 in dogs after oral administration. J Pharm Pharm Sci. 2004;7(1):8–12.
   PubMed Web of Science ®Google Scholar
• Al-Amodi YA, Hosny KM, Alharbi WS, Safo MK, El-Say KM. Investigating the potential of transmucosal delivery of febuxostat from oral lyophilized tablets loaded with a self-nanoemulsifying delivery system. Pharmaceutics. 2020;12(534):1–18. doi:10.3390/pharmaceutics12060534
   Web of Science ®Google Scholar
• El-Say KM, Ahmed TAA, Ahmed OAA, Elimam H. Enhancing the hypolipidemic effect of simvastatin in poloxamer-induced hyperlipidemic rats via liquisolid approach: pharmacokinetic and pharmacodynamic evaluation. AAPS PharmSciTech. 2020;21(6):223. doi:10.1208/s12249-020-01754-5
   PubMed Web of Science ®Google Scholar
• El-Say KM, Ahmed TA, Ahmed OAA, Hosny KM, Abd-Allah FI. Self-nanoemulsifying lyophilized tablets for flash oral transmucosal delivery of vitamin K: development and clinical evaluation. J Pharm Sci. 2017;106(9):2447–2456. doi:10.1016/j.xphs.2017.01.001
   PubMed Web of Science ®Google Scholar
• Dudhipala N, Veerabrahma K. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: pharmacokinetic and pharmacodynamic evaluation. Eur J Pharm Biopharm. 2017;110:47–57. doi:10.1016/j.ejpb.2016.10.022
   PubMed Web of Science ®Google Scholar
• Dobiášová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583–588. doi:10.1016/S0009-9120(01)00263-6
   PubMed Web of Science ®Google Scholar
• Kanthe PS, Patil BS, Bagali S, Deshpande A, Shaikh GB, Aithala M. Atherogenic index as a predictor of cardiovascular risk among women with different grades of obesity. Int J Collab Res Intern Med Public Heal. 2012;4(10):1767–1774.
   Google Scholar
• Hasan KMM, Tamanna N, Haque MA. Biochemical and histopathological profiling of Wistar rat treated with Brassica napus as a supplementary feed. Food Sci Hum Wellness. 2018;7(1):77–82. doi:10.1016/j.fshw.2017.12.002
   Google Scholar
• Duarte T, Da Cruz IBM, Barbisan F, Capelleto D, Moresco RN, Duarte MMMF. The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism. Pharmacogenomics J. 2016;16(6):501–506. doi:10.1038/tpj.2015.91
   PubMed Web of Science ®Google Scholar